CVS Health Price Target Raised by Mizuho Analyst Sees Upside Potential Can Nifty 50 Reach 2800030000 by FY27End Smallcase Managers Stay Optimistic Amid 9 YTD Decline Hyderabad Police Launches AIPowered Multilingual Complaint App Implications for Public Sector Digitalization FTSE Russell Accelerates LargeCap Entry into Key Benchmarks The Decline of the Office Lunch From Luxury to Burden in Modern Workplace Culture LIC and HDFC Bank Lead Wednesdays Market Movers EQIX Q1 2026 Earnings EPS Miss Slightly Below Estimates Stock Edges Higher Taoping Inc TAOP Q2 2011 Earnings Significant EPS Miss Amid Challenging Environment Trane Technologies Q1 2026 Earnings EPS Beat Drives Modest Share Gains Amid Steady Operational Execution YALA Q1 2026 Earnings EPS of 016 Drives 165 Stock Gain Despite Limited Data LEGN Q1 2026 Earnings EPS Misses by a Wide Margin at 030 Shares Rally 493 Bloom Energy Q1 2026 Earnings Massive EPS Surprise Highlights Operational Efficiency AN2 Therapeutics Stock Slips Modestly Amid Consolidation Near Support Levels ANTX Oaktree Acquisition Corp III Life Sciences Unit OACCU Holds Steady at 1069 as Trading Remains Quiet Relay Therapeutics RLAY Holds Near Support as Shares Edge Lower VisionSys AI VSA Surges Over 27 on Heavy Volume Key Levels to Watch Origin Materials ORGN Holds Steady at 147 Key Levels in Focus Companies Continue to Expand Prediction Market Investments Amid Regulatory Uncertainty AVAH Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Declines XChange TECINC XHG Holds Steady at 098 Consolidation or Stalemate Curis Inc Q1 2026 Earnings Deep EPS Miss as PreRevenue Biotech Continues Development JOUT Q1 2026 Earnings Earnings Beat Amidst Challenging Outdoor Market Conditions MPT Q1 2026 Earnings EPS Surges Past Estimates Yet Shares Edge Lower BJ Q1 2026 Earnings EPS Beats Estimates but Shares Slide 825 on Mixed Signals TAL Q1 2026 Earnings Massive EPS Beat Amidst Revenue Uncertainty Oxford Lane Capital Corp 625 Series 2027 Term Preferred Shares OXLCP Q4 2025 Earnings EPS Misses Estimates by 74 as Shares Edge Higher ATOS Q1 2026 Earnings Narrowing Loss Exceeds Expectations Amid Clinical Progress